BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36151984)

  • 1. The opioid epidemic and the impact on opioid prescribing in hospice and palliative care: a qualitative study.
    Borders J; Letvak S
    Int J Palliat Nurs; 2022 Sep; 28(9):426-435. PubMed ID: 36151984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid epidemic and prescribing in hospice and palliative care: a review of the literature.
    Borders JR; Letvak S; Amirehsani KA; Ross R; Phifer N
    Int J Palliat Nurs; 2021 Jul; 27(5):255-261. PubMed ID: 34292770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing Trends in Opioid Prescribing on Discharge to Hospice Care.
    Furuno JP; Noble BN; Fromme EK; Hartung DM; Tjia J; Lynn M; Teno JM
    J Pain Symptom Manage; 2021 Nov; 62(5):1026-1033. PubMed ID: 33848567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
    Antunes B; Bowers B; Winterburn I; Kelly MP; Brodrick R; Pollock K; Majumder M; Spathis A; Lawrie I; George R; Ryan R; Barclay S
    BMJ Support Palliat Care; 2020 Sep; 10(3):343-349. PubMed ID: 32546559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oregon hospice nurses and social workers' assessment of physician progress in palliative care over the past 5 years.
    Goy ER; Jackson A; Harvath T; Miller LL; Delorit MA; Ganzini L
    Palliat Support Care; 2003 Sep; 1(3):215-9. PubMed ID: 16594421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The poor use of methadone in Italian hospices.
    Mercadante S; Valle A; Agnelotti C; Caruselli A
    Support Care Cancer; 2013 Aug; 21(8):2225-8. PubMed ID: 23503802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Buprenorphine Prescribing for Opioid Use Disorder in Hospice and Palliative Care.
    Janet Ho J; Jones KF; Sager Z; Neale K; Childers JW; Loggers E; Merlin JS
    J Pain Symptom Manage; 2022 Aug; 64(2):119-127. PubMed ID: 35561938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers.
    Gerlach LB; Turnwald M; Geczi K; O'Neil T; Watkins D; Bynum JPW; Maust DT
    J Am Med Dir Assoc; 2023 Sep; 24(9):1297-1302.e1. PubMed ID: 37230152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid prescribing attitudes of palliative care physicians versus other specialists: a questionnaire-based survey.
    Dzierzanowski T; Kozlowski M
    Postgrad Med J; 2022 Feb; 98(1156):119-123. PubMed ID: 33414178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
    Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
    J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caring for Patients With Opioid Misuse or Substance Use Disorders in Hospice: A National Survey.
    Langmann GA; Childers J; Merlin JS
    J Palliat Med; 2024 Feb; 27(2):209-215. PubMed ID: 37824806
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustainable access to appropriate opioids for palliative care patients in Australia-preventing the need for crisis management.
    Reed K
    J Pain Palliat Care Pharmacother; 2020 Mar; 34(1):13-21. PubMed ID: 31825713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Opioids, Including Misuse and Addiction, in Patients With Serious Illness in Ambulatory Palliative Care: A Qualitative Study.
    Merlin JS; Young SR; Arnold R; Bulls HW; Childers J; Gauthier L; Giannitrapani KF; Kavalieratos D; Schenker Y; Wilson JD; Liebschutz JM
    Am J Hosp Palliat Care; 2020 Jul; 37(7):507-513. PubMed ID: 31763926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A National Survey of Challenges Faced by Hospices During the Opioid Crisis: Estimates of Pain Medication Shortages, Missing Medications, and Opioids Left in the Home Post-Death.
    Cagle JG; McPherson ML; Frey JJ; Sacco P; Ware OD; Hoffmann D; Guralnik JM
    J Pain Symptom Manage; 2021 Oct; 62(4):738-746. PubMed ID: 33652093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Survey of Hospice and Palliative Care Physicians Regarding Palliative Sedation Practices.
    Lux MR; Protus BM; Kimbrel J; Grauer P
    Am J Hosp Palliat Care; 2017 Apr; 34(3):217-222. PubMed ID: 26543063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical assistance in dying legislation: Hospice palliative care providers' perspectives.
    Joolaee S; Ho A; Serota K; Hubert M; Buchman DZ
    Nurs Ethics; 2022 Feb; 29(1):231-244. PubMed ID: 34538192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Italian survey on the attitudes in treating breakthrough cancer pain in hospice.
    Mercadante S; Villari P; Casuccio A
    Support Care Cancer; 2011 Jul; 19(7):979-83. PubMed ID: 20602120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relevance of State Laws Regulating Opioid Prescribing for People Living With Serious Illness.
    Jones KF; Abdulhay LB; Orris SR; Merlin JS; Schenker Y; Bulls HW
    J Pain Symptom Manage; 2022 Aug; 64(2):89-99. PubMed ID: 35561937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State variation in antipsychotic and benzodiazepine prescribing among hospice beneficiaries in the United States.
    Gerlach LB; Zhang L; Strominger J; Teno J; Bynum JPW; Maust DT
    J Am Geriatr Soc; 2022 Dec; 70(12):3637-3640. PubMed ID: 35942950
    [No Abstract]   [Full Text] [Related]  

  • 20. Opioid-prescribing Outcomes of Medicare Beneficiaries Managed by Nurse Practitioners and Physicians.
    Muench U; Spetz J; Jura M; Guo C; Thomas C; Perloff J
    Med Care; 2019 Jun; 57(6):482-489. PubMed ID: 31008896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.